Skip to content

NovoCure NVCR Line of Credit Outstanding

Line of Credit Outstanding at other companies

Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
$150M-50.0%
Karman Holdings Inc. logo
Karman Holdings Inc.KRMN
$0-100%
Dorman Products logo
Dorman ProductsDORM
$15M
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$146K-98.0%
Winmark logo
WinmarkWINA
$30M0.0%
VIA
Via Renewables, Inc.VIA
$130M+28.7%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's line of credit outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's line of credit outstanding?
NovoCure (NVCR) reported line of credit outstanding of $195.46M in Q1 2026.
How has NovoCure's line of credit outstanding changed year-over-year?
NovoCure's line of credit outstanding increased by 100.6% year-over-year, from $97.45M to $195.46M.
What does line of credit outstanding mean?
This represents the total amount drawn and currently owed under revolving credit facilities provided by financial institutions. It serves as a primary indicator of the company's reliance on external short-term financing to fund operations or bridge liquidity gaps. Investors monitor this to evaluate the company's debt burden and its flexibility in accessing capital.